Coronavirus Update:What patients and families need to know
T-Cells from recovered COVID-19 patients show promise to protect vulnerable patients from infection
T-cells taken from the blood of people who recovered from a COVID-19 infection can be successfully multiplied in the lab and maintain the ability to effectively target proteins that are key to the virus’s function, according to a study published Oct. 26, 2020, in the journal Blood. Learn more about this study.
About the Expert
Catherine Bollard, M.D., M.B.Ch.B.
Director, Center for Cancer & Immunology Research
Bosworth Chair for Cancer Biology
Director, Program for Cell Enhancement and Technologies for Immunotherapy (CETI)
Attending Physician, Division of Bone and Marrow Transplantation
Michael Keller, MD
Co-Director, Translational Research Laboratory
Make an Appointment
Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.
Make it happen